期刊
WORLD DEVELOPMENT
卷 36, 期 1, 页码 144-158出版社
PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.worlddev.2007.02.013
关键词
vitamin A deficiency; biofortification; Golden Rice; disability-adjusted life years; cost-effectiveness; India
Vitamin A deficiency (VAD) affects millions of people, causing serious health problems. Golden Rice (GR), which has been genetically engineered to produce beta-carotene, is being proposed as a remedy. While this new technology has aroused controversial debates, its actual impact remains unclear. We develop a methodology for ex ante evaluation, taking into account health and nutrition details, as well as socioeconomic and policy factors. The framework is used for empirical analyses in India. Given broad public support, GR could more than halve the disease burden of VAD. Juxtaposing health benefits and overall costs suggests that GR could be very cost-effective. (C) 2007 Elsevier Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据